By modulating critical signaling pathways, such as TGF-β/Smad, NOTCH1, Wnt/β-catenin, and Sonic Hedgehog (SHH), these natural compounds hold great promise for enhancing the efficacy of existing therapies of gastric cancer (Figure 1 and Table 1). This evidence concerns the gene TGFB1 and gastric cancer.